Details

Autor(en) / Beteiligte

• Xu, Pengfei
• Richter, Julia
• Blatz, Annette
• Gärtner, Fabian
• Alberts, Roland
• Azoitei, Anca
• Makori, Wycliffe Arika
• Meessen, Sabine
• Knippschild, Uwe
• Günes, Cagatay

Titel

Downregulation of ORP3 Correlates with Reduced Survival of Colon Cancer Patients with Advanced Nodal Metastasis and of Female Patients with Grade 3 Colon Cancer

Ist Teil von

• International journal of molecular sciences, 2020-08, Vol.21 (16), p.5894

Ort / Verlag

Switzerland: MDPI AG

Erscheinungsjahr

2020

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Genome instability is an essential hallmark in tumor development, including colorectal cancer. We have recently identified the oxysterol binding protein-related protein 3 (ORP3), also known as oxysterol binding protein-like 3 (OSBPL3), as a novel ploidy-control gene, whose knock-out leads to aneuploidy induction and promotes tumor formation, indicating that ORP3 is a bona fide tumor suppressor protein. Here we analyzed expression of in a cohort ( = 206) of colon cancer patients in relation to patient survival. We show that low mRNA levels correlate with reduced survival of patients with advanced nodal metastasis (N2). While patient survival does not associate with grading when the whole cohort is evaluated, importantly, low mRNA levels associate with worse survival of female patients with grade 3 colon cancer. Similarly, low mRNA levels associate with worse survival of grade 3 colon cancer patients 70 years of age and younger while low mRNA levels seem to be beneficial for colon cancer patients with a T2 tumor size. Together, the data show that expression is downregulated during colon cancer progression, which correlates with reduced patient survival. Thus, mRNA levels may be a prognostic marker for better stratification of colon cancer patients.